Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Noiiglutide in Obese Subjects Without Diabetes
NCT04799327Phase 2Unknown
- Sponsor
- Hengrui
- Start
- Mar 2021
- Primary completion
- May 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of noiiglutide in obesity, sponsored by Hengrui. Status: unknown.
02
Drugs
noiiglutide
03
Conditions
obesity
Beyond the preview
Go deeper on NCT04799327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04799327.